Cullinan Therapeutics, Inc. (CGEM) Profit Margin
Cullinan Therapeutics, Inc. (CGEM) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -346.14% |
| 2022-12-31 | 111214.00% |
| 2023-12-31 | -30632.40% |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How CGEM compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| NVST | Envista Holdings Corporation | 1.73% |
| ICUI | ICU Medical Inc. | 0.03% |
| AMN | AMN Healthcare Services Inc | -3.51% |
| ETON | Eton Pharmaceuticals Inc. | -5.75% |
| VTRS | Viatris Inc. | -24.58% |
These are five companies in the same sector as CGEM with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cullinan Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("CGEM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CGEM | $20.84 | +1.21% | 0.60M |
| 3 | ||||
| 4 | ||||
| 5 |